Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Members of Congress are under scrutiny for buying and selling stocks that would benefit from a bill banning China biotech companies. Several lawmakers hold positions that could profit from the legislation, raising concerns about potential conflicts of interest. The trading activity is not illegal but is drawing attention for the privileged access to information these lawmakers may have.
I'm shocked that there hasn't been major media coverage of this yet. Last month, I posted a report on a suspicious trade I noticed from a U.S. Senator. Senator Tommy Tuberville bought stock in a company called Humacyte. It has now risen 154% since then. Humacyte is a small… https://t.co/6D9w0GPKQw
RU shocked? Members of Congress buy and sell stocks that would gain from bill banning China biotech companies @endpts @ZacharyBrennan https://t.co/sjj4LizIKV
Members of Congress buy and sell stocks that would gain from bill banning China biotech companies, from @ZacharyBrennan https://t.co/vfQTCw2ix0
